Archive | The 100% Fund RSS for this section

C17 Call for LOI: The 100% Fund Grant Competition and the C17Operating Grant Competition

C17 is pleased to announce the inaugural round of The 100% Fund C17 Grant Competition and Round 21 of the C17 Research Network Operating Grant Competition.

The C17 Operating Grant Competition is focused on multicenter, multidisciplinary pediatric oncology/hematology research.

The purpose of The 100% Fund Grant Competition is to target directly pediatric cancers that are rare and hard to treat—cancers that have not responded to available therapies. Applications addressing the cancer types below will be considered for the fall 2017 competition.

In recognition of its 30th anniversary, Childhood Cancer Canada established The 100% Fund to challenge the odds for children and teens who do not, yet, have their cure.

Please see the calls for LOI, LOI forms and C17 Award Guide linked below. The application form and guidance document also can be downloaded from the C17 website ( under Committees> Research Network. The submission deadline for C17 LOIs is December 14, 2017 at 4 PM MST.



NEW C17 GRANT COMPETITION —The 100% Fund. Watch for a call for applications in the areas of infant ALL, rhabdomyosarcoma and Ewing sarcoma (click to read more!)

We are thrilled to announce a new C17 grant competition that will be run in addition to our regular C17 Operating Grant completion.  Watch for a call for Letters of Intent* this month!

Nearly one in five children diagnosed with cancer will not survive. For children with rare and hard to treat cancers, the odds can be far worse.

The 100% Fund has been created to challenge these odds. In recognition of its 30th anniversary, Childhood Cancer Canada (CCC) is proud to partner with organizations with a shared passion to help fund research for children who do not, yet, have their cure.   The list is growing, but confirmed organizations as of September 12th are:

By building on new and exciting research initiatives in Canada and around the world, The 100% Fund ( will pave the way for collaborative research into cutting-edge therapies for tumours that have not responded to currently available treatments.

CCC will partner with C17 Council and its C17 Research Network to administer the grants. As a national research organization representing leading pediatric oncology programs across Canada, the experts at the C17 know the priorities of children and their families that have been impacted by childhood cancer.

* Applications will include a full letter of intent with a 3 page research proposal.  Successful LOI will advance to the full grant application stage.  Applicants not funded in the funding round currently in progress will be able to submit to this upcoming competition.